Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials. Lipton RB, Gandhi P, Tassorelli C, Reuter U, et al. Neurology 2025;104:e210212.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lipton RB, Gandhi P, Tassorelli C, Reuter U, et al. Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials. Neurology 2025;104:e210212.
PMID: 39715475